Standard Life Aberdeen »

Galera Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Galera Therapeutics (GRTX) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Galera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galera Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galera Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $131k 898k 0.15

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding Galera Therapeutics

GSA Capital Partners
Blackstone Group
Standard Life Aberdeen
Citadel Advisors
Vanguard Group
Summit Trail Advisors
Manchester Financial
Virtu Financial
Royal Bank of Canada
Kestra Advisory Services
Good Life Advisors
Level Four Advisory Services
Bank of New York Mellon
Vontobel Holding
Hrt Financial

View all funds holding Galera Therapeutics